QF
OCRX

QVT Financial’s Ocera Therapeutics, Inc. OCRX Stock Holding History

QVT Financial’s Portfolio OCRX Stock Details OCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-906,286
Closed -$1.9M – 91
2016
Q4 		$1.9M Sell
906,286
-25,800
-3% -$60.2K 0.06% 80
2016
Q3 		$2.33M Hold
932,086
– – 0.09% 64
2016
Q2 		$1.49M Hold
932,086
– – 0.1% 71
2016
Q1 		$2.45M Hold
932,086
– – 0.15% 78
2015
Q4 		$2.91M Buy
932,086
+179,508
+24% +$613K 0.16% 74
2015
Q3 		$2.32M Buy
752,578
+162,451
+28% +$625K 0.08% 81
2015
Q2 		$2.24M Hold
590,127
– – 0.03% 79
2015
Q1 		$2.78M Sell
590,127
-21,500
-4% -$124K 0.15% 75
2014
Q4 		$3.81M Sell
611,627
-58,500
-9% -$342K 0.19% 80
2014
Q3 		$3.22M Sell
670,127
-24,100
-3% -$139K 0.17% 70
2014
Q2 		$5.06M Sell
694,227
-17,900
-3% -$143K 0.27% 68
2014
Q1 		$7.18M Sell
712,127
-16,700
-2% -$239K 0.41% 61
2013
Q4 		$8.64M Buy
728,827
+633,357
+663% +$5.92M 0.51% 55
2013
Q3 		$809K Sell
95,470
-1
-0% -$8 0.06% 70
2013
Q2 		$538K Buy
+95,471
New +$593K 0.04% 60

Other funds holding OCRX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

QVT Financial's OCRX Position: Q1 2017 in Review

QVT Financial sold out of Ocera Therapeutics, Inc. (OCRX) in Q1 2017, closing a stake of 906,286 shares — an estimated $1.9M sold.

QVT Financial first reported a position in OCRX in Q2 2013 and held it in 15 quarters. The position peaked at $8.64M in Q4 2013. 26 funds tracked by Wall St. Rank hold OCRX as of Q1 2017.

  • QVT Financial reported no remaining Ocera Therapeutics, Inc. position as of Q1 2017 after selling out during the quarter.
  • QVT Financial sold 906,286 Ocera Therapeutics, Inc. shares in Q1 2017, an estimated $1.9M.
  • QVT Financial first reported a position in Ocera Therapeutics, Inc. in Q2 2013 and held it in 15 quarters.
  • QVT Financial's Ocera Therapeutics, Inc. position peaked at $8.64M in Q4 2013.
  • 26 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q1 2017.

Based on QVT Financial's 13F filing for Q1 2017, filed 15 May 2017.